EX-VIVO EXPERIMENTAL THROMBOSIS IN VARIANTS OF VON-WILLEBRAND DISEASE

被引:0
|
作者
FRESSINAUD, E
FEDERICI, AB
CASTAMAN, G
MANNUCCI, PM
MEYER, D
机构
[1] UNIV MILAN,ANGELO BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,I-20122 MILAN,ITALY
[2] SAN BORTOLO HOSP,CTR HEMOPHILIA & THROMBOSIS,VICENZA,ITALY
[3] SAN BORTOLO HOSP,DEPT HEMATOL,VICENZA,ITALY
[4] HOP BICETRE,INSERM,U143,PARIS,FRANCE
来源
COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES | 1993年 / 316卷 / 10期
关键词
VON-WILLEBRAND FACTOR; PLATELET ADHESION; THROMBUS FORMATION; COLLAGEN; EX-VIVO PERFUSION MODEL; VON-WILLEBRAND DISEASE;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In order to compare quantitative and qualitative abnormalities of von Willebrand factor (vWF) in mediating platelet adhesion and thrombus formation, we performed ex vivo perfusion studies with native blood from patients with various types of von Willebrand disease (vWD). We studied twenty-seven patients having either a quantitative (types I, III) or a qualitative (type II) abnormality of vWF. At high shear rate (2 600 s-1) we found that the defect in platelet collagen interactions in type I vWD was at the level of thrombus formation whereas platelet adhesion was normal. In the patients with a qualitative abnormality of vWF (type II), platelet adhesion and thrombus formation were markedly decreased at high shear conditions, indicating that the interaction of normal vWF with the platelet glycoprotein Ib is an essential initial step in platelet collagen interactions.
引用
收藏
页码:1260 / 1265
页数:6
相关论文
共 50 条
  • [41] The role of ultralarge multimers in recombinant human von Willebrand factor - a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease
    Turecek, Peter L.
    Spannagl, Michael
    Kragh, Thorsten
    Allmaier, Guenter
    Turecek, Marietta
    Schrenk, Gerald
    Gritsch, Herbert
    Obermann-Slupetzky, Ortrun
    Ewenstein, Bruce M.
    Valentino, Leonard A.
    HAMOSTASEOLOGIE, 2017, 37 : S15 - S25
  • [42] A MONOCLONAL-ANTIBODY (B724) TO VON-WILLEBRAND-FACTOR RECOGNIZING AN EPITOPE WITHIN THE A1 DISULFIDE LOOP (CYS509-CYS695) DISCRIMINATES BETWEEN TYPE 2A AND TYPE 2B VON-WILLEBRAND DISEASE
    CHRISTOPHE, O
    ROUAULT, C
    OBERT, B
    PIETU, G
    MEYER, D
    GIRMA, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) : 195 - 203
  • [43] The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels
    Yamamoto, J
    Ishii, I
    Okita, N
    Sasaki, Y
    Yamashita, T
    Matsuoka, A
    Muraki, T
    Giddings, JC
    Watanabe, S
    Seki, J
    JAPANESE JOURNAL OF PHYSIOLOGY, 1997, 47 (05) : 431 - 441
  • [44] DIGITAL IMAGE-ANALYSIS OF PLATELET-EXTRACELLULAR MATRIX INTERACTIONS - STUDIES IN VON-WILLEBRAND DISEASE PATIENTS AND ASPIRIN-TREATED DONORS
    DIAZRICART, M
    CARRETERO, M
    CASTILLO, R
    ORDINAS, A
    ESCOLAR, G
    HAEMOSTASIS, 1994, 24 (04) : 219 - 229
  • [45] PLATELET RISTOCETIN COFACTOR (RICOF) IN PATIENTS WITH TYPE-I PLATELET NORMAL VON-WILLEBRAND DISEASE CORRELATES WITH PLASMA RICOF PEAK AFTER DESMOPRESSIN INFUSION
    CASTAMAN, G
    RODEGHIERO, F
    THROMBOSIS RESEARCH, 1995, 77 (04) : 383 - 384
  • [46] DIFFERENT ORGANIZATION OF VON-WILLEBRAND-FACTOR OLIGOMERS IN TYPE-2A AND TYPE-2B VON-WILLEBRAND-DISEASE VARIANTS - EFFECTS OF DDAVP INFUSION AND PROTEASE INHIBITORS
    CASONATO, A
    PONTARA, E
    BERTOMORO, A
    DANNHAUSER, D
    SECCHIERO, S
    ZANINOTTO, M
    GIROLAMI, A
    ANNALS OF HEMATOLOGY, 1995, 71 (04) : 189 - 194
  • [47] Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses
    Kim, Hee-Jung
    Kim, Soon Ki
    Yoo, Ki-Young
    Lee, Ki-O
    Yun, Jae Won
    Kim, Sun-Hee
    Kim, Hee-Jin
    Park, Sang Kyu
    ANNALS OF LABORATORY MEDICINE, 2019, 39 (06) : 545 - 551
  • [48] Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms
    Ines Woods, Adriana
    Paiva, Juvenal
    Marina Primrose, Debora
    Noemi Blanco, Alicia
    Sanchez-Luceros, Analia
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07) : 862 - 874
  • [49] A time-tested ex vivo model of thrombosis: From pathophysiology to drug development and disease application
    Becker, Richard C.
    THROMBOSIS RESEARCH, 2010, 126 (05) : 363 - 364
  • [50] The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediated ex vivo platelet function in acute myocardial infarction
    Spiel, Alexander O.
    Mayr, Florian B.
    Ladani, Nathalie
    Wagner, Patricia G.
    Schaub, Robert G.
    Gilbert, James C.
    Jilma, Bernd
    PLATELETS, 2009, 20 (05) : 334 - 340